Musto, P; Anderson, K C; Attal, M; Richardson, P G; Badros, A; Hou, J; Comenzo, R; Du, J; Durie, B G M; San Miguel, J; Einsele, H; Chen, W M; Garderet, L; Pietrantuono, G; Hillengass, J; Kyle, R A; Moreau, P; Lahuerta, J J; Landgren, O; Ludwig, H; Larocca, A; Mahindra, A; Cavo, M; Mazumder, A; Mccarthy, P L; Nouel, A; Rajkumar, S V; Reiman, A; Serra, E R; Sezer, O; Terpos, E; Turesson, I; Usmani, S; Weiss, B M; Palumbo, A, Second primary malignancies in multiple myeloma: an overview and IMWG consensus, «ANNALS OF ONCOLOGY», 2017, 28, pp. 228 - 245 [articolo]
Manuela Mancini, Cecilia Monaldi, Sara De Santis, Cristina Papayannidis, Michela Rondoni, Maria Chiara Abbenante, Luana Bavaro, Margherita Martelli, Elisa Ficarra, Giulia Paciello, Viviana Guadagnuolo, Maria Chiara Fontana, Marco Manfrini, Roberta Zanotti, Livio Pagano, Francesco Albano, Fabio Ciceri, Chiara Elena, Patrizia Tosi, Massimo Delledonne, Peter Valent, Michele Cavo, Giovanni Martinelli, Simona Soverini, SETD2 Non-Genomic Loss of Function and p53 Functional Inactivation in Advanced Systemic Mastocytosis (SM): Pathogenetic and Therapeutic Implications, «BLOOD», 2017, 130, pp. 2944 - 2944 [abstract]
Castagnetti, Fausto; Gugliotta, Gabriele; Breccia, Massimo; Iurlo, Alessandra; Levato, Luciano; Albano, Francesco; Vigneri, Paolo; Abruzzese, Elisabetta; Rossi, Giuseppe; Rupoli, Serena; Cavazzini, Francesco; Martino, Bruno; Orlandi, Ester; Pregno, Patrizia; Annunziata, Mario; Usala, Emilio; Tiribelli, Mario; Sica, Simona; Bonifacio, Massimiliano; Fava, Carmen; Gherlinzoni, Filippo; Bocchia, Monica; Soverini, Simona; Bochicchio, Maria Teresa; Cavo, Michele; Giovanni, Martinelli; Saglio, Giuseppe; Pane, Fabrizio; Baccarani, Michele; Rosti, Gianantonio, The BCR-ABL1 transcript type influences response and outcome in Philadelphia chromosome-positive chronic myeloid leukemia patients treated frontline with imatinib, «AMERICAN JOURNAL OF HEMATOLOGY», 2017, 92, pp. 797 - 805 [articolo]
De Benedittis, Caterina; Papayannidis, Cristina; Venturi, Claudia; Maria Chiara, Abbenante; Paolini, Stefania; Parisi, Sarah; Sartor, Chiara; Cavo, Michele; Martinelli, Giovanni; Soverini, Simona, The clonal evolution of two distinct T315I-positive BCR-ABL1 subclones in a Philadelphia-positive acute lymphoblastic leukemia failing multiple lines of therapy: a case report, «BMC CANCER», 2017, 17, Article number: 523, pp. 1 - 8 [articolo]Open Access
Parisi, Sarah; Lecciso, MARIANGELA STEFANIA; Ocadlikova, Darina; Salvestrini, Valentina; Ciciarello, Marilena; Forte, Dorian; Corradi, Giulia; Cavo, Michele; Curti, Antonio, The more, the better: "Do the right thing" for natural killer immunotherapy in acute myeloid leukemia, «FRONTIERS IN IMMUNOLOGY», 2017, 8, Article number: 1330, pp. 1 - 7 [articolo]Open Access
Perricone, Margherita; Polverelli, Nicola; Martinelli, Giovanni; Catani, Lucia; Ottaviani, Emanuela; Zuffa, Elisa; Franchini, Eugenia; Dizdari, Arbana; Forte, Dorian; Sabattini, Elena; Cavo, Michele; Vianelli, Nicola; Palandri, Francesca, The relevance of a low JAK2V617F allele burden in clinical practice: a monocentric study, «ONCOTARGET», 2017, 8, pp. 37239 - 37249 [articolo]
Anderson, Kenneth C; Auclair, Daniel; Kelloff, Gary J; Sigman, Caroline C; Avet-Loiseau, Herve; Farrell, Ann T; Gormley, Nicole J; Kumar, Shaji K; Landgren, Ola; Munshi, Nikhil C; Cavo, Michele; Davies, Faith E; Di Bacco, Alessandra; Dickey, Jennifer S; Gutman, Steven I; Higley, Howard R; Hussein, Mohamad A; Jessup, J Milburn; Kirsch, Ilan R; Little, Richard F; Loberg, Robert D; Lohr, Jens G; Mukundan, Lata; Omel, James L; Pugh, Trevor J; Reaman, Gregory H; Robbins, Michael D; Sasser, A Kate; Valente, Nancy; Zamagni, Elena, The Role of Minimal Residual Disease Testing in Myeloma Treatment Selection and Drug Development: Current Value and Future Applications, «CLINICAL CANCER RESEARCH», 2017, 23, pp. 3980 - 3993 [articolo]
Forte, Dorian; Salvestrini, Valentina; Corradi, Giulia; Rossi, Lara; Catani, Lucia; Lemoli, ROBERTO MASSIMO; Cavo, Michele; Curti, Antonio, The tissue inhibitor of metalloproteinases-1 (TIMP-1) promotes survival and migration of acute myeloid leukemia cells through CD63/PI3K/Akt/p21 signaling, «ONCOTARGET», 2017, 8, pp. 2261 - 2274 [articolo]
Lebret, T; Casas, A; Cavo, Michele; Woll, P. J; Deleplace, C; Kennedy, C; Schoen, P; Jackisch, C., The use of bisphosphonates in the management of bone involvement from solid tumours and haematological malignancies - a European survey, «EUROPEAN JOURNAL OF CANCER CARE», 2017, 26, Article number: e12490, pp. 1 - 16 [articolo]
Zamagni, Elena; Cavo, Michele, Toward a GEP-based PET in myeloma, «BLOOD», 2017, 130, pp. 2 - 3 [articolo]
Gugliotta, Gabriele; Sudo, Makoto; Cao, Qi; Lin, De-chen; Sun, Haibo; Takao, Sumiko; Le Moigne, Ronan; Rolfe, Mark; Gery, Sigal; Müschen, Markus; Cavo, Michele; Koeffler, H. Phillip, Valosin-Containing Protein/p97 as a Novel Therapeutic Target in Acute Lymphoblastic Leukemia, «NEOPLASIA», 2017, 19, pp. 750 - 761 [articolo]Open Access
Simonetti, Giorgia; Padella, Antonella; Manfrini, Marco; FARIA DO VALLE, Italo; Papayannidis, Cristina; Baldazzi, Carmen; Fontana, MARIA CHIARA; Guadagnuolo, Viviana; Ferrari, Anna; Zago, Elisa; Garonzi, Marianna; Bernardi, Simona; Astolfi, Annalisa; Abbenante, Mariachiara; Marconi, Giovanni; Zuffa, Elisa; Franchini, Eugenia; Lacobucci, Ilaria; Cavo, Michele; Ottaviani, Emanuela; Testoni, Nicoletta; Ferrarini, Alberto; Delledonne, Massimo; Haferlach, Torsten; Remondini, Daniel; Martinelli, Giovanni, A cell cycle-related genomic and transcriptomic signature distinguish aneuploid and euploid acute myeloid leukemia, «CANCER RESEARCH», 2016, 76, pp. 90 - 90 [abstract]
Weisel, Katja C; Dimopoulos, Meletios A; Moreau, Philippe; Lacy, Martha Q; Song, Kevin W; Delforge, Michel; Karlin, Lionel; Goldschmidt, Hartmut; Banos, Anne; Oriol, Albert; Alegre, Adrian; Chen, Christine; Cavo, Michele; Garderet, Laurent; Ivanova, Valentina; Martinez-Lopez, Joaquin; Knop, Stefan; Yu, Xin; Hong, Kevin; Sternas, Lars; Jacques, Christian; Zaki, Mohamed H; San Miguel, Jesus, Analysis of renal impairment in MM-003, a phase III study of pomalidomide + low - dose dexamethasone versus high - dose dexamethasone in refractory or relapsed and refractory multiple myeloma, «HAEMATOLOGICA», 2016, 101, pp. 872 - 878 [articolo]Open Access
Dimopoulos, Meletios A; Moreau, Philippe; Palumbo, Antonio; Joshua, Douglas; Pour, Ludek; Hájek, Roman; Facon, Thierry; Ludwig, Heinz; Oriol, Albert; Goldschmidt, Hartmut; Rosiñol, Laura; Straub, Jan; Suvorov, Aleksandr; Araujo, Carla; Rimashevskaya, Elena; Pika, Tomas; Gaidano, Gianluca; Weisel, Katja; Goranova-Marinova, Vesselina; Schwarer, Anthony; Minuk, Leonard; Masszi, Tamás; Karamanesht, Ievgenii; Offidani, Massimo; Hungria, Vania; Spencer, Andrew; Orlowski, Robert Z; Gillenwater, Heidi H; Mohamed, Nehal; Feng, Shibao; Chng, Wee-Joo; Cavo, M, Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study, «THE LANCET ONCOLOGY», 2016, 17, pp. 27 - 38 [articolo]
Maria Chiara Fontana, Viviana Guadagnuolo, Cristina Papayannidis, Giovanni Marconi, Giorgia Simonetti, Antonella Padella, Marco Manfrini, Barbara Santacroce, Margherita Perricone, Silvia Lo Monaco, Emanuela Ottaviani, Simona Soverini, Michele Cavo, Giovanni Martinelli, Chromothripsis in AML patients: A new mechanism of cancer initiation and progression, «CANCER RESEARCH», 2016, 76, pp. 3582 - 3582 [abstract]
